Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Baseline Serum Vitamin A and D Levels Determine Benefit of Oral Vitamin A&D Supplements to Humoral Immune Responses Following Pediatric Influenza Vaccination.

Patel N, Penkert RR, Jones BG, Sealy RE, Surman SL, Sun Y, Tang L, DeBeauchamp J, Webb A, Richardson J, Heine R, Dallas RH, Ross AC, Webby R, Hurwitz JL.

Viruses. 2019 Sep 30;11(10). pii: E907. doi: 10.3390/v11100907.

2.

Background check: Profound differences in serum antibody isotypes among C57BL/6 mouse substrains discourage substrain interchanges in immunology experiments.

Jones BG, Penkert RR, Surman SL, Sealy RE, Pelletier S, Berns H, Hurwitz JL.

Immunol Lett. 2019 Aug 19;216:9-11. doi: 10.1016/j.imlet.2019.05.011. [Epub ahead of print] No abstract available.

PMID:
31437463
3.

Influences of Vitamin A on Vaccine Immunogenicity and Efficacy.

Penkert RR, Rowe HM, Surman SL, Sealy RE, Rosch J, Hurwitz JL.

Front Immunol. 2019 Jul 17;10:1576. doi: 10.3389/fimmu.2019.01576. eCollection 2019.

4.

Will Attention by Vaccine Developers to the Host's Nuclear Hormone Levels and Immunocompetence Improve Vaccine Success?

Sealy RE, Jones BG, Surman SL, Penkert RR, Pelletier S, Neale G, Hurwitz JL.

Vaccines (Basel). 2019 Feb 27;7(1). pii: E26. doi: 10.3390/vaccines7010026. Review.

5.

Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable.

Piccini JP, Xu H, Cox M, Matsouaka RA, Fonarow GC, Butler J, Curtis AB, Desai N, Fang M, McCabe PJ, Page Ii RL, Turakhia M, Russo AM, Knight BP, Sidhu M, Hurwitz JL, Ellenbogen KA, Lewis WR; Get With The Guidelines-AFIB Clinical Working Group and Hospitals.

Circulation. 2019 Mar 19;139(12):1497-1506. doi: 10.1161/CIRCULATIONAHA.118.035909.

PMID:
30700141
6.

Taxonomy of the order Mononegavirales: second update 2018.

Maes P, Amarasinghe GK, Ayllón MA, Basler CF, Bavari S, Blasdell KR, Briese T, Brown PA, Bukreyev A, Balkema-Buschmann A, Buchholz UJ, Chandran K, Crozier I, de Swart RL, Dietzgen RG, Dolnik O, Domier LL, Drexler JF, Dürrwald R, Dundon WG, Duprex WP, Dye JM, Easton AJ, Fooks AR, Formenty PBH, Fouchier RAM, Freitas-Astúa J, Ghedin E, Griffiths A, Hewson R, Horie M, Hurwitz JL, Hyndman TH, Jiāng D, Kobinger GP, Kondō H, Kurath G, Kuzmin IV, Lamb RA, Lee B, Leroy EM, Lǐ J, Marzano SL, Mühlberger E, Netesov SV, Nowotny N, Palacios G, Pályi B, Pawęska JT, Payne SL, Rima BK, Rota P, Rubbenstroth D, Simmonds P, Smither SJ, Song Q, Song T, Spann K, Stenglein MD, Stone DM, Takada A, Tesh RB, Tomonaga K, Tordo N, Towner JS, van den Hoogen B, Vasilakis N, Wahl V, Walker PJ, Wang D, Wang LF, Whitfield AE, Williams JV, Yè G, Zerbini FM, Zhang YZ, Kuhn JH.

Arch Virol. 2019 Apr;164(4):1233-1244. doi: 10.1007/s00705-018-04126-4.

PMID:
30663023
7.

Complex sex-biased antibody responses: estrogen receptors bind estrogen response elements centered within immunoglobulin heavy chain gene enhancers.

Jones BG, Sealy RE, Penkert RR, Surman SL, Maul RW, Neale G, Xu B, Gearhart PJ, Hurwitz JL.

Int Immunol. 2019 Mar 5;31(3):141-156. doi: 10.1093/intimm/dxy074.

PMID:
30407507
8.

Antiviral Vaccines: Successes and Prospects.

Hurwitz JL.

Viral Immunol. 2018 Mar;31(2):79. doi: 10.1089/vim.2017.29025.jlh. Epub 2018 Feb 14. No abstract available.

PMID:
29443662
9.

Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field.

Kulkarni PS, Hurwitz JL, Simões EAF, Piedra PA.

Viral Immunol. 2018 Mar;31(2):195-203. doi: 10.1089/vim.2017.0147. Epub 2018 Jan 16. Review.

10.

Vaccines for the Paramyxoviruses and Pneumoviruses: Successes, Candidates, and Hurdles.

Russell CJ, Simões EAF, Hurwitz JL.

Viral Immunol. 2018 Mar;31(2):133-141. doi: 10.1089/vim.2017.0137. Epub 2018 Jan 11. Review.

11.

Multi-Envelope HIV-1 Vaccine Development: Two Targeted Immune Pathways, One Desired Protective Outcome.

Hurwitz JL, Bonsignori M.

Viral Immunol. 2018 Mar;31(2):124-132. doi: 10.1089/vim.2017.0144. Epub 2018 Jan 9. Review.

12.

Inflammatory molecule reduction with hydroxyurea therapy in children with sickle cell anemia.

Penkert RR, Hurwitz JL, Thomas P, Rosch J, Dowdy J, Sun Y, Tang L, Hankins JS.

Haematologica. 2018 Feb;103(2):e50-e54. doi: 10.3324/haematol.2017.177360. Epub 2017 Nov 16. No abstract available.

13.

Enhanced CD103 Expression and Reduced Frequencies of Virus-Specific CD8+ T Cells Among Airway Lymphocytes After Influenza Vaccination of Mice Deficient in Vitamins A + D.

Surman SL, Jones BG, Woodland DL, Hurwitz JL.

Viral Immunol. 2017 Dec;30(10):737-743. doi: 10.1089/vim.2017.0086. Epub 2017 Nov 13.

14.

Prevnar-13 vaccine failure in a mouse model for vitamin A deficiency.

Penkert RR, Iverson A, Rosch JW, Hurwitz JL.

Vaccine. 2017 Nov 1;35(46):6264-6268. doi: 10.1016/j.vaccine.2017.09.069. Epub 2017 Oct 9.

15.

Hypothesis: RNA and DNA Viral Sequence Integration into the Mammalian Host Genome Supports Long-Term B Cell and T Cell Adaptive Immunity.

Hurwitz JL, Jones BG, Charpentier E, Woodland DL.

Viral Immunol. 2017 Nov;30(9):628-632. doi: 10.1089/vim.2017.0099. Epub 2017 Oct 13.

PMID:
29028182
16.

A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge.

Russell CJ, Jones BG, Sealy RE, Surman SL, Mason JN, Hayden RT, Tripp RA, Takimoto T, Hurwitz JL.

Virology. 2017 Sep;509:60-66. doi: 10.1016/j.virol.2017.05.021. Epub 2017 Jun 9.

17.

Low Retinol-Binding Protein and Vitamin D Levels Are Associated with Severe Outcomes in Children Hospitalized with Lower Respiratory Tract Infection and Respiratory Syncytial Virus or Human Metapneumovirus Detection.

Hurwitz JL, Jones BG, Penkert RR, Gansebom S, Sun Y, Tang L, Bramley AM, Jain S, McCullers JA, Arnold SR.

J Pediatr. 2017 Aug;187:323-327. doi: 10.1016/j.jpeds.2017.04.061. Epub 2017 May 31.

18.

Saccharomyces cerevisiae-derived virus-like particle parvovirus B19 vaccine elicits binding and neutralizing antibodies in a mouse model for sickle cell disease.

Penkert RR, Young NS, Surman SL, Sealy RE, Rosch J, Dormitzer PR, Settembre EC, Chandramouli S, Wong S, Hankins JS, Hurwitz JL.

Vaccine. 2017 Jun 22;35(29):3615-3620. doi: 10.1016/j.vaccine.2017.05.022. Epub 2017 May 26.

19.

CD4+ T cells support establishment of RSV-specific IgG and IgA antibody secreting cells in the upper and lower murine respiratory tract following RSV infection.

Sealy RE, Surman SL, Hurwitz JL.

Vaccine. 2017 May 9;35(20):2617-2621. doi: 10.1016/j.vaccine.2017.03.073. Epub 2017 Apr 11.

20.

Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus.

Samarasinghe AE, Melo RC, Duan S, LeMessurier KS, Liedmann S, Surman SL, Lee JJ, Hurwitz JL, Thomas PG, McCullers JA.

J Immunol. 2017 Apr 15;198(8):3214-3226. doi: 10.4049/jimmunol.1600787. Epub 2017 Mar 10.

21.

Vitamin A differentially regulates cytokine expression in respiratory epithelial and macrophage cell lines.

Penkert RR, Jones BG, Häcker H, Partridge JF, Hurwitz JL.

Cytokine. 2017 Mar;91:1-5. doi: 10.1016/j.cyto.2016.11.015. Epub 2016 Dec 8.

22.
23.

Antibody-secreting cells in respiratory tract tissues in the absence of eosinophils as supportive partners.

Sealy RE, Surman SL, Vogel P, Hurwitz JL.

Int Immunol. 2016 Nov;28(11):559-564. Epub 2016 Jul 18.

24.

An Epithelial Integrin Regulates the Amplitude of Protective Lung Interferon Responses against Multiple Respiratory Pathogens.

Meliopoulos VA, Van de Velde LA, Van de Velde NC, Karlsson EA, Neale G, Vogel P, Guy C, Sharma S, Duan S, Surman SL, Jones BG, Johnson MD, Bosio C, Jolly L, Jenkins RG, Hurwitz JL, Rosch JW, Sheppard D, Thomas PG, Murray PJ, Schultz-Cherry S.

PLoS Pathog. 2016 Aug 9;12(8):e1005804. doi: 10.1371/journal.ppat.1005804. eCollection 2016 Aug.

25.

Binding of estrogen receptors to switch sites and regulatory elements in the immunoglobulin heavy chain locus of activated B cells suggests a direct influence of estrogen on antibody expression.

Jones BG, Penkert RR, Xu B, Fan Y, Neale G, Gearhart PJ, Hurwitz JL.

Mol Immunol. 2016 Sep;77:97-102. doi: 10.1016/j.molimm.2016.07.015. Epub 2016 Aug 3.

26.

Original Research: Parvovirus B19 infection in children with sickle cell disease in the hydroxyurea era.

Hankins JS, Penkert RR, Lavoie P, Tang L, Sun Y, Hurwitz JL.

Exp Biol Med (Maywood). 2016 Apr;241(7):749-54. doi: 10.1177/1535370216636723. Epub 2016 Mar 2.

27.

Unveiling Unexpected Immune Activities Induced by Your Pneumococcal Vaccine.

Hurwitz JL, Tuomanen E.

MBio. 2016 Feb 23;7(1):e00137-16. doi: 10.1128/mBio.00137-16.

28.

Hotspots for Vitamin-Steroid-Thyroid Hormone Response Elements Within Switch Regions of Immunoglobulin Heavy Chain Loci Predict a Direct Influence of Vitamins and Hormones on B Cell Class Switch Recombination.

Hurwitz JL, Penkert RR, Xu B, Fan Y, Partridge JF, Maul RW, Gearhart PJ.

Viral Immunol. 2016 Mar;29(2):132-6. doi: 10.1089/vim.2015.0104. Epub 2016 Jan 7.

29.

Vitamin Supplementation at the Time of Immunization with a Cold-Adapted Influenza Virus Vaccine Corrects Poor Mucosal Antibody Responses in Mice Deficient for Vitamins A and D.

Surman SL, Penkert RR, Jones BG, Sealy RE, Hurwitz JL.

Clin Vaccine Immunol. 2016 Jan 6;23(3):219-27. doi: 10.1128/CVI.00739-15.

30.

Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses.

Russell CJ, Hurwitz JL.

Expert Rev Vaccines. 2016;15(2):189-200. doi: 10.1586/14760584.2016.1114418. Epub 2015 Dec 9. Review.

31.

Murine Monoclonal Antibodies for Antigenic Discrimination of HIV-1 Envelope Proteins.

Sealy RE, Jones BG, Surman SL, Branum K, Howlett NM, Flynn PM, Hurwitz JL.

Viral Immunol. 2016 Jan-Feb;29(1):64-70. doi: 10.1089/vim.2015.0078. Epub 2015 Nov 6.

32.

Vitamin A deficient mice exhibit increased viral antigens and enhanced cytokine/chemokine production in nasal tissues following respiratory virus infection despite the presence of FoxP3+ T cells.

Penkert RR, Surman SL, Jones BG, Sealy RE, Vogel P, Neale G, Hurwitz JL.

Int Immunol. 2016 Mar;28(3):139-52. doi: 10.1093/intimm/dxv064. Epub 2015 Oct 27.

33.

Retinol binding protein and vitamin D associations with serum antibody isotypes, serum influenza virus-specific neutralizing activities and airway cytokine profiles.

Jones BG, Oshansky CM, Bajracharya R, Tang L, Sun Y, Wong SS, Webby R, Thomas PG, Hurwitz JL.

Clin Exp Immunol. 2016 Feb;183(2):239-47. doi: 10.1111/cei.12718. Epub 2015 Nov 24.

35.

Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children.

Adderson E, Branum K, Sealy RE, Jones BG, Surman SL, Penkert R, Freiden P, Slobod KS, Gaur AH, Hayden RT, Allison K, Howlett N, Utech J, Allay J, Knight J, Sleep S, Meagher MM, Russell CJ, Portner A, Hurwitz JL.

Clin Vaccine Immunol. 2015 Mar;22(3):298-303. doi: 10.1128/CVI.00618-14. Epub 2014 Dec 31.

36.

Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats.

Zhan X, Slobod KS, Jones BG, Sealy RE, Takimoto T, Boyd K, Surman S, Russell CJ, Portner A, Hurwitz JL.

Int Immunol. 2015 May;27(5):229-36. doi: 10.1093/intimm/dxu107. Epub 2014 Dec 4.

37.

Respiratory syncytial virus human experimental infection model: provenance, production, and sequence of low-passaged memphis-37 challenge virus.

Kim YI, DeVincenzo JP, Jones BG, Rudraraju R, Harrison L, Meyers R, Cehelsky J, Alvarez R, Hurwitz JL.

PLoS One. 2014 Nov 21;9(11):e113100. doi: 10.1371/journal.pone.0113100. eCollection 2014.

38.

Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model.

Jones BG, Sealy RE, Surman SL, Portner A, Russell CJ, Slobod KS, Dormitzer PR, DeVincenzo J, Hurwitz JL.

Vaccine. 2014 May 30;32(26):3264-73. doi: 10.1016/j.vaccine.2014.03.088. Epub 2014 Apr 14.

39.

Oral retinyl palmitate or retinoic acid corrects mucosal IgA responses toward an intranasal influenza virus vaccine in vitamin A deficient mice.

Surman SL, Jones BG, Sealy RE, Rudraraju R, Hurwitz JL.

Vaccine. 2014 May 7;32(22):2521-4. doi: 10.1016/j.vaccine.2014.03.025. Epub 2014 Mar 21.

40.

Intranasal administration of retinyl palmitate with a respiratory virus vaccine corrects impaired mucosal IgA response in the vitamin A-deficient host.

Surman SL, Jones BG, Rudraraju R, Sealy RE, Hurwitz JL.

Clin Vaccine Immunol. 2014 Apr;21(4):598-601. doi: 10.1128/CVI.00757-13. Epub 2014 Feb 19.

41.

Respiratory tract epithelial cells express retinaldehyde dehydrogenase ALDH1A and enhance IgA production by stimulated B cells in the presence of vitamin A.

Rudraraju R, Jones BG, Surman SL, Sealy RE, Thomas PG, Hurwitz JL.

PLoS One. 2014 Jan 22;9(1):e86554. doi: 10.1371/journal.pone.0086554. eCollection 2014.

42.

Non-random lymphocyte distribution among virus-infected cells of the respiratory tract.

Rudraraju R, Sealy RE, Surman SL, Thomas PG, Dayton BH, Hurwitz JL.

Viral Immunol. 2013 Dec;26(6):378-84. doi: 10.1089/vim.2013.0033.

43.

Characterization of innate responses to influenza virus infection in a novel lung type I epithelial cell model.

Rosenberger CM, Podyminogin RL, Askovich PS, Navarro G, Kaiser SM, Sanders CJ, McClaren JL, Tam VC, Dash P, Noonan JG, Jones BG, Surman SL, Peschon JJ, Diercks AH, Hurwitz JL, Doherty PC, Thomas PG, Aderem A.

J Gen Virol. 2014 Feb;95(Pt 2):350-62. doi: 10.1099/vir.0.058438-0. Epub 2013 Nov 16.

44.

Inhibition of primary clinical isolates of human parainfluenza virus by DAS181 in cell culture and in a cotton rat model.

Jones BG, Hayden RT, Hurwitz JL.

Antiviral Res. 2013 Nov;100(2):562-6. doi: 10.1016/j.antiviral.2013.09.014. Epub 2013 Sep 27.

45.

Respiratory syncytial virus: current progress in vaccine development.

Rudraraju R, Jones BG, Sealy R, Surman SL, Hurwitz JL.

Viruses. 2013 Feb 5;5(2):577-94. doi: 10.3390/v5020577. Review.

46.

Differential localization and function of antibody-forming cells responsive to inactivated or live-attenuated influenza virus vaccines.

Sealy R, Webby RJ, Crumpton JC, Hurwitz JL.

Int Immunol. 2013 Mar;25(3):183-95. doi: 10.1093/intimm/dxs107. Epub 2012 Nov 8.

47.

Vitamin A deficiency disrupts vaccine-induced antibody-forming cells and the balance of IgA/IgG isotypes in the upper and lower respiratory tract.

Surman SL, Rudraraju R, Sealy R, Jones B, Hurwitz JL.

Viral Immunol. 2012 Aug;25(4):341-4. doi: 10.1089/vim.2012.0023. Epub 2012 Jul 19.

48.

UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV.

Jones BG, Sealy RE, Zhan X, Freiden PJ, Surman SL, Blanchard JL, Hurwitz JL.

Vaccine. 2012 May 2;30(21):3188-95. doi: 10.1016/j.vaccine.2012.03.001. Epub 2012 Mar 14.

49.

Reduced frequencies and heightened CD103 expression among virus-induced CD8(+) T cells in the respiratory tract airways of vitamin A-deficient mice.

Rudraraju R, Surman SL, Jones BG, Sealy R, Woodland DL, Hurwitz JL.

Clin Vaccine Immunol. 2012 May;19(5):757-65. doi: 10.1128/CVI.05576-11. Epub 2012 Mar 7.

50.

Vorinostat/SAHA-induced apoptosis in malignant mesothelioma is FLIP/caspase 8-dependent and HR23B-independent.

Hurwitz JL, Stasik I, Kerr EM, Holohan C, Redmond KM, McLaughlin KM, Busacca S, Barbone D, Broaddus VC, Gray SG, O'Byrne KJ, Johnston PG, Fennell DA, Longley DB.

Eur J Cancer. 2012 May;48(7):1096-107. doi: 10.1016/j.ejca.2011.11.009. Epub 2011 Dec 10.

PMID:
22154545

Supplemental Content

Loading ...
Support Center